DNALabs: Mid-Year Review

As we reach the midway point of 2023, I am delighted to celebrate our remarkable achievements during the first six months of this year. We have witnessed tremendous growth, building upon our past successes and forging new paths to success.

One of the highlights of the year thus far was our participation in the prestigious A4M conference held in Orlando, Florida. This conference provided us with an excellent opportunity to showcase our cutting-edge DNA testing solutions and establish connections with like-minded professionals and innovators in the field. I am thrilled to report that we met numerous outstanding new clients during the conference, solidifying our position as a trusted provider of advanced DNA testing solutions.

Our team at DNALabs understands the importance of collaboration and the power of partnerships. I am pleased to share that we have formed several new partnerships during the first half of 2023. These alliances are the result of shared values and a common vision for advancing genetic research and improving the lives of people worldwide. With these partnerships, we aim to combine our expertise and resources to deliver even more impactful solutions for our clients.

However, it doesn’t stop there. DNALabs is continuously working on forging additional partnerships that will enhance our capabilities and expand our reach. We are committed to building a robust network of collaborators who share our passion for pushing the boundaries of scientific discovery and making a positive difference in society.

Looking ahead, I am filled with optimism as we embark on the second half of the year. We have exciting projects in the pipeline that will further advance the field of DNA analysis and revolutionize how we understand and utilize genetic information. Our dedicated team of scientists, researchers, and professionals is working tirelessly to develop groundbreaking solutions that will shape the future of personalized medicine and genetic testing solutions.

We also recognize that our success is not solely based on scientific breakthroughs but also on the trust and satisfaction of our clients. We remain committed to providing unparalleled customer service, ensuring that our clients’ needs are met and their expectations surpassed. By delivering exceptional results and maintaining strong relationships, we aim to become the go-to partner for all DNA analysis requirements.

Additionally, I would like to mention the growing interest we have received from investors who recognize the potential of DNALabs. As we continue to make progress in the field of DNA testing and foster strategic partnerships, we are pleased to have caught the attention of individuals seeking opportunities in this rapidly evolving industry. DNALabs presents an exciting prospect for those interested in supporting advancements in genetic research and personalized medicine. We remain open to discussions with potential investors who share our vision and are passionate about making a positive impact on society.

As we celebrate our achievements during the first half of 2023, I extend my heartfelt gratitude to our valued clients, dedicated employees, and partners who have been instrumental in our success. Your unwavering support and belief in our mission inspire us to reach new heights.

In conclusion, I am thrilled about what lies ahead for DNALabs in the coming months. We are poised to capitalize on the opportunities before us and make a lasting impact in the field of DNA analysis. Together, we will continue to drive innovation, collaborate with brilliant minds, and create a future where genetic information transforms lives.

Thank you for your trust and support.


Moni Lustig,
Chief Executive Officer


Questions for our CEO about investment opportunities? Book a call here.